Thrombosis of the cerebral veins and sinuses affects mainly young adults and children. This
potentially disabling or fatal condition is usually not diagnosed until a week after the onset of …

This chapter about hemorrhagic complications of anticoagulant treatment is part of the
seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Background The standard initial treatment of hemodynamically stable patients with
pulmonary embolism is intravenous unfractionated heparin, requiring laboratory monitoring …

Background: The current standard initial therapies for deep venous thrombosis are low-
molecular-weight heparin and unfractionated heparin. In a dose-ranging study of patients …

Background: Low-molecular-weight heparin has greatly simplified the management of deep
venous thrombosis. However, for patients who present with pulmonary embolism, the role of …

Background The safety and efficacy of various management strategies for patients receiving
oral anticoagulants (OACs) who need to undergo surgery or invasive procedures are …

Background Treatment of cerebral venous sinus thrombosis with anticoagulants has been
controversial. Anticoagulants may prevent new venous infarcts, neurologic deterioration and …

Venous thromboembolism is a common condition affecting 7.1 persons per 10 000 person-
years among community residents. Incidence rates for venous thromboembolism are higher …

Background: New treatments are available for treatment of venous thromboembolism.
Purpose: To review the evidence on the efficacy of interventions for treatment of deep …

Making a diagnosis of deep vein thrombosis (DVT) requires both clinical assessment and
objective testing because the clinical features are nonspecific and investigations can be …